Intermittent fasting: human studies show less dramatic benefits than animal research
Intermittent fasting, a popular dietary approach, has gained a reputation for aiding weight loss and potentially reducing risks of cancer and cognitive decline. However, recent evidence from human studies raises questions about the strength and consistency of these claims. While animal studies, particularly in mice, flies, and worms, have shown significant benefits like increased longevity and reduced disease incidence, human data has been less conclusive. For instance, intermittent fasting typically leads to about 5% weight loss in humans, comparable to other diet strategies, and offers some metabolic benefits such as decreased cholesterol and blood pressure, especially for individuals with poorer health at the outset. These effects are generally less pronounced in humans than in animals. Researchers attribute this discrepancy partly to fundamental biological differences, such as metabolic rate, and the genetic uniformity of lab animals compared to human variability. A major challenge in human nutrition research is accurately tracking dietary intake, as self-reported food diaries are often unreliable due to memory lapses or underreporting. New technologies like smart forks, wearable cameras, and tooth sensors are being developed to provide more objective data, and combining these with biomarkers from blood and urine tests could offer more precise insights into human eating patterns, potentially bridging the gap between animal and human study outcomes.
